Immunology and Microbiology
Antigen Specificity
17%
Bacteroides fragilis
10%
Cancer Cell
12%
Cancer Immunotherapy
19%
Cancer Vaccine
8%
CD4
22%
CD8
14%
Colon
17%
Cytokine
22%
Cytotoxic T Cell
9%
Cytotoxic T-Cell
32%
Dendritic Cell
28%
DNA Vaccine
7%
Gene Expression
8%
Granulocyte Macrophage Colony-Stimulating Factor
17%
Human Papillomavirus Type 16
11%
Immune Checkpoint Blockade
13%
Immune Response
42%
Immune System
13%
Immunocompetent Cell
15%
Immunosuppressive Drug
10%
Immunotherapy
49%
Interleukin 17
13%
Interleukin 2
7%
Lymphocyte
8%
Macrophage
10%
Major Histocompatibility Complex
8%
Monospecific Antibody
8%
Mouse
53%
Myeloid
9%
Neck
12%
Neoantigen
12%
Programmed Death-Ligand 1
16%
Prostate
8%
Regulatory T Cell
29%
Squamous Cell
9%
STAT3
9%
T Cell
100%
T Cell Receptor
36%
T-Helper Cell
20%
Thymocyte
17%
Thymus
7%
Transcription Factors
8%
Tumor Antigen
24%
Tumor Cell
34%
Tumor Immunity
8%
Tumor Vaccine
11%
Vaccination Policy
14%
Vaccine Efficacy
30%
Wild Type
7%
Keyphrases
Allogeneic
6%
Anti-PD-1
10%
Anti-tumor Response
6%
Antigen-specific
7%
Antitumor Immune Response
10%
Cancer Cells
7%
Cancer Immunotherapy
22%
Cancer Therapy
7%
Cancer Vaccine
6%
CD-8
6%
CD4+ T Cells
8%
CD8+ T Cells
17%
Colorectal Cancer
6%
Costimulatory Molecules
6%
Dendritic Cells
14%
DNA Vaccine
5%
Glioblastoma
6%
Granulocyte Colony-stimulating Factor (G-CSF)
13%
HPV16
7%
Immune Cells
6%
Immune Checkpoint Blockade
12%
Immune Checkpoint Inhibitors
6%
Immune Response
16%
Immune System
7%
In Cancer
15%
Interleukin-2
8%
Melanoma
11%
Myeloid-derived Suppressor Cells
6%
Neoadjuvant
11%
Neoantigen
9%
Nivolumab
7%
Non-small Cell Lung Cancer (NSCLC)
7%
Overall Survival
6%
PD-1 Blockade
7%
Programmed Death-ligand 1 (PD-L1)
32%
Prostate Cancer
11%
Recombinant
6%
Regulatory T Cells
6%
T Cell Receptor
16%
T Cells
35%
Therapeutic Vaccine
9%
Thymocytes
9%
Tumor
51%
Tumor Antigen
16%
Tumor Cells
22%
Tumor Growth
6%
Tumor Immunity
26%
Tumor Microenvironment
9%
Tumor-specific
6%
Vaccination
10%
Medicine and Dentistry
Antigen Specificity
7%
Biological Marker
7%
Cancer Cell
9%
Cancer Immunotherapy
10%
Cancer Therapy
8%
Clear Cell Renal Cell Carcinoma
5%
Clinical Trial
8%
Colorectal Cancer
7%
CTLA-4
5%
Cytokine
6%
Cytotoxic T-Cell
11%
Disease
5%
DNA Mismatch Repair
5%
Ganglioglioma
7%
Glioblastoma
5%
Granulocyte Macrophage Colony Stimulating Factor
7%
Head and Neck Cancer
5%
Head and Neck Squamous Cell Carcinoma
6%
Human Papillomavirus Type 16
5%
Immune Checkpoint Blockade
11%
Immune Response
19%
Immune System
7%
Immunocompetent Cell
10%
Immunotherapy
41%
In Vitro
6%
Interferon
7%
Interleukin 17
5%
Lung Cancer
8%
Lymphocyte
5%
Macrophage
5%
Malignant Neoplasm
33%
Metastatic Carcinoma
6%
Myeloid-Derived Suppressor Cell
6%
Neoplasm
72%
Nivolumab
8%
Nodular Melanoma
21%
Non Small Cell Lung Cancer
9%
Overall Survival
9%
Programmed Death 1 Ligand 1
5%
Programmed Death-Ligand 1
19%
Prostate Cancer
15%
Radiation Therapy
7%
Specific Tumor
6%
STAT3 Protein
6%
T Cell
36%
T-Helper Cell
8%
Tumor Antigen
10%
Tumor Cell
14%
Tumor Microenvironment
13%
Wart Virus
6%
